A fortune in fat cells?
This company seeks cell-based medical therapies that use fat cells instead of embryonic stem cells. Its stock is on a roll.
The stock has hit 14 new highs in the past 20 trading sessions and hit new highs in four of the past five sessions. Price appreciation in the past 65 days has been 100%, and BarChart's technical indicators are hitting 13 out of 13 "buy" signals for a 100% buy rating.
On Wall Street, the five analysts following the stock have four buy recommendations and one underperform rating (which hasn't changed since January 2008.) The analysts' consensus for sales growth is 17.7% with EPS growth of 54.5% expected next year.
I always try to see what some of the other sites think about a stock in case I missed some negative signals. On Wall Street Survivor, Mark's checklist has a Survivor Sentiment rating of 5 of 5, a fundamental rating of 5 of 5 and a technical rating of 5 of 5. The Motley Fool CAPS members think the stock will outperform the market 132 to 20 with the All Stars giving it a 34 to 9 vote. The Wall Street guys Motley Fool follows vote 4 to 0.
This stock passes the three tests I use:
- The stock is hitting new highs better than 50% of the time and has a BarChart technical indicator rating of better than 80%
- If Wall Street brokerages are following the stock, they are not trashing it. Why would I buy something if brokerage firms are publishing negative reports and having their brokers call clients soliciting sells? I don't spit in the wind
- I try to get confirmation from other rating sites that the stock has better than a 50/50 chance to beat the market.
I'm adding Cytori Therapeutics to my Wall Street Survivor public portfolio because it meets my three major criteria. If I can't find a stock that meets my criteria, then I don't buy anything that day.
I'm also doing a little trimming my portfolio. I never sell a stock because I found a better stock, but I do sell a stock from my portfolio if it fails to keep trading above its 50 day moving average. This week both Korea Electric Power (KEP) and the Limited Brands (LTD) began trading below their 50 day moving averages, so they were trimmed.
Disclosure: No positions in CYTX at the time of publication.
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Remy Cointreau says it was 'adversely affected' by China's anti-extravagance policy.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.